Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-25 @ 7:17 PM
NCT ID: NCT03388632
Term: Hypotension
Organ System: Vascular disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (5.0)
Notes: None
Study: NCT03388632
Study Brief: Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 2 View
EG001 0 0 1 View
EG002 0 0 2 View
EG003 0 0 2 View
EG004 2 2 18 View
EG005 0 0 2 View
EG006 0 0 1 View
EG007 0 0 2 View
EG008 0 0 1 View